$ADPT Adaptive Biotechnologies Corp Insider Trading Week 46/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adaptive Biotechnologies Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Adaptive Biotechnologies Corp in week 46/2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 49,560 | |
Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 66,240 | |
Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 82,920 | |
Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 48.54 | 900 | 43,686 | 1,778,180 | 1.8 M to 1.8 M (-0.05 %) |
Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 47.75 | 4,360 | 208,190 | 1,779,080 | 1.8 M to 1.8 M (-0.24 %) |
Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 46.69 | 3,773 | 176,161 | 1,783,440 | 1.8 M to 1.8 M (-0.21 %) |
Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 49,560 | |
Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 45.60 | 7,647 | 348,703 | 1,787,213 | 1.8 M to 1.8 M (-0.43 %) |
Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 66,240 | |
Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 82,920 | |
Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 48.52 | 13,480 | 654,050 | 1,778,180 | 1.8 M to 1.8 M (-0.75 %) |
Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 48.54 | 900 | 43,686 | 1,778,180 | 1.8 M to 1.8 M (-0.05 %) |
Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 47.64 | 2,000 | 95,280 | 1,791,660 | 1.8 M to 1.8 M (-0.11 %) |
Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 47.75 | 4,360 | 208,190 | 1,779,080 | 1.8 M to 1.8 M (-0.24 %) |
Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 46.68 | 1,200 | 56,016 | 1,793,660 | 1.8 M to 1.8 M (-0.07 %) |
Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 46.69 | 3,773 | 176,161 | 1,783,440 | 1.8 M to 1.8 M (-0.21 %) |
Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 45.60 | 7,647 | 348,703 | 1,787,213 | 1.8 M to 1.8 M (-0.43 %) |
Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 46.68 | 5,633 | 262,948 | 1,778,180 | 1.8 M to 1.8 M (-0.32 %) |
Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 45.84 | 11,047 | 506,394 | 1,783,813 | 1.8 M to 1.8 M (-0.62 %) |
Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 48.52 | 13,480 | 654,050 | 1,778,180 | 1.8 M to 1.8 M (-0.75 %) |
Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 47.64 | 2,000 | 95,280 | 1,791,660 | 1.8 M to 1.8 M (-0.11 %) |
Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 46.68 | 1,200 | 56,016 | 1,793,660 | 1.8 M to 1.8 M (-0.07 %) |
Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 46.68 | 5,633 | 262,948 | 1,778,180 | 1.8 M to 1.8 M (-0.32 %) |
Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 45.84 | 11,047 | 506,394 | 1,783,813 | 1.8 M to 1.8 M (-0.62 %) |
Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |